Project Grant HT94252510905
Award Date 11/1/25
Completion Date 10/31/26
Dollars Obligated $250K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Galveston, TX 77555, USA
Similar Awards
- The University of Texas Southwestern Medical Center was awarded a $2,641,871 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from May 1, 2023 through April 30, 2027 to comprehensively upregulate and stabilize frataxin mRNA using antisense oligonucleotides. The goal of this research is to transform health care for service members and the public by investigating medical solutions for the...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $544,892.00 to the University of Texas Health Science Center at Houston (UTHealth) to develop a novel peptide-drug conjugate for precision-targeted DNA damage in neuroendocrine tumors. The award period is from August 1, 2025 to July 31, 2028. This research aims to transform healthcare for military service members, veterans, and the broader public by advancing...
- This $999,392 Project Grant award from the U.S. Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports biomedical research by the University of Houston System to study the role of the PRMT5 protein in the treatment of lupus nephritis. The award, effective September 1, 2025, will fund this research project over a period of 4 years through August 31, 2029. The University of Houston System, a prominent Hispanic Serving Institution, has a substantial track...
- This federal Project Grant award of $249,999.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is supporting research conducted by the University of Maryland, Baltimore (UMB) to gain insights into multiple sclerosis pathology. The research project will leverage 7-T MRI and multiomics analysis of serologic samples to advance the understanding of this neurological disorder. The award period runs from August 15, 2024 to August 14,...
- This federal Project Grant award of $319,999.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at the University of Maryland, Baltimore on the relationship between cortical lesions, meningeal inflammation, and Epstein-Barr virus infection in multiple sclerosis, as observed using 7-T MRI. The award period runs from November 1, 2024 to October 31, 2026. The research aims to advance understanding of the underlying...
- This Project Grant award, in the amount of $431,750.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Houston System. The funding will support research aimed at understanding the role of H19X noncoding RNAs in the pathogenesis of myotonic dystrophy type I, a genetic disorder affecting muscle function. This 2-year project, beginning on December 1, 2024 and ending on November 30, 2026, will be conducted at...
- This $249,986 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports research by The University of Texas Southwestern Medical Center (UT Southwestern) to understand genetic determinants of multiple sclerosis (MS) progression using longitudinal cohorts. The two-year grant, awarded on September 1, 2024, will enable UT Southwestern to conduct advanced biomedical research focused on transforming...
- This $1,565,298.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by The University of Texas Health Science Center at San Antonio to target the METTL3 enzyme in order to overcome drug resistance in metastatic clear cell renal cell carcinoma. The project aims to develop innovative medical solutions to address this critical health challenge for military personnel and the broader public. The award period runs...
- The Defense Health Agency has awarded a $760,844.00 Project Grant to the Texas A&M University System Health Science Center to conduct research under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, awarded on September 15, 2023 with a completion date of September 14, 2026, will fund research titled "Targeting the MIF/CD74 Immune Axis to Treat GWI Astrocyte, Neuronal, and Cognitive Dysfunction." This research aims to investigate medical...
- This $2,399,474.00 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) will support the University of Texas Medical Branch at Galveston (UTMB) in conducting research on "Wound Stabilization to Prevent Combat Infections." The award, which runs from September 1, 2024 through August 31, 2028, will enable UTMB to develop innovative medical solutions for addressing infectious disease challenges...